Comparison
Phenylpiracetam Hydrazide vs Phenylpiracetam
Hydrazide: longer, sharper, lower dose — but more niche. Phenylpiracetam: classic, proven, slightly gentler.
Phenylpiracetam Hydrazide
Racetam / β-Aryl-GABA Analog
Nootropict½ Inferred 4–6 hours (parent fonturacetam 3–5h); subjective duration 6–10h
Phenylpiracetam
Stimulant Racetam / DAT Inhibitor
Nootropict½ 3–5 hours
Effectiveness Profile
Phenylpiracetam Hydrazide
Phenylpiracetam
At a Glance
| Phenylpiracetam Hydrazide | Phenylpiracetam | |
|---|---|---|
| Type | Nootropic | Nootropic |
| Legal status | Research | Grey-Market |
| Half-life | Inferred 4–6 hours (parent fonturacetam 3–5h); subjective duration 6–10h | 3–5 hours |
| Preferred route | Oral | Oral |
| Dose frequency | as-needed | as-needed |
| Beginner dose | 25–50 mg | 100–100 mg |
| Intermediate dose | 50–100 mg | 100–200 mg |
| Advanced dose | 100–150 mg | 200–300 mg |
| Cycle length | 1–8 wks | 1–4 wks |
| Bioavailability | — | 100% |
| Time to peak | 0.75h | 1h |
| Active duration | 8h | 6h |
| Storage | Room temperature, sealed, protected from light and moisture | Room temperature, dry, away from light |
| PCT required | No | No |
| Ancillaries required | No | No |
| Safe for women | Yes | Yes |
Verdict
Phenylpiracetam Hydrazide wins for: sharper focus/tactile stimulation per mg, longer subjective duration (6–10+ hours), less frequent dosing needed, and more potent dopaminergic kick.
Phenylpiracetam wins for: documented safety profile over decades, fewer unknowns around hepatic risk, easier sourcing, and a gentler/comfier ride for broader use-cases. It is also slightly less likely to trigger rapid tolerance for most users.
Pick A or B?
Pick Phenylpiracetam Hydrazide if:
- A pronounced, stimulant-like focus boost is wanted in a lower dose range (50–75mg).
- Durability — an 8–10 hour tail — matters more than a short-lived punch.
- Previous experience with phenylpiracetam left you wanting a stronger/longer effect.
- The chemistry lab is exploring newer racetam analogues and mechanism tweaks.
- Single-use or occasional high-output scenarios are prioritized over daily use.
Pick Phenylpiracetam if:
- Classical racetam effects are preferred, with a robust safety history and fewer unknowns.
- Proven cognitive or motor drive is needed for exams, heavy training, or demanding work.
- Sourcing from established nootropic suppliers is important.
- Minimal hepatotoxicity risk is a deciding factor, especially in longer research blocks.
- Cholinergic, mild-stimulant effects are the target, rather than full-bore dopaminergic stimulation.
This comparison is presented for informational and educational purposes only. The compounds described may be research chemicals, prescription-only, or regulated substances in your jurisdiction. Consult a qualified medical professional before using any compound. This is not medical advice.